Sung-Nam Lim

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim et al. · Blood · 2015 · 181 citations · Full text

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Je‐Hwan Lee, Hawk Kim, Young‐Don Joo et al. · Journal of Clinical Oncology · 2017 · 81 citations

High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era

Deok‐Hwan Yang, Gyeong‐Won Lee, Sung-Nam Lim et al. · Leukemia Research · 2016 · 64 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +7

Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy

Joo-Seop Chung, Dong‐Yeop Shin, Sung-Nam Lim et al. · Annals of Hematology · 2016 · 29 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +7